Nicole Pinto
Nicole Pinto
PhD Candidate, Western University
Verified email at uwo.ca
Title
Cited by
Cited by
Year
Self-assembly enhances the strength of fibers made from vimentin intermediate filament proteins
N Pinto, FC Yang, A Negishi, MC Rheinstädter, TE Gillis, DS Fudge
Biomacromolecules 15 (2), 574-581, 2014
392014
Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer
AC Nichols, M Black, J Yoo, N Pinto, A Fernandes, B Haibe-Kains, ...
BMC Pharmacology and Toxicology 15 (1), 1-10, 2014
222014
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
N Pinto, M Black, K Patel, J Yoo, JS Mymryk, JW Barrett, AC Nichols
Journal of oncology 2014, 2014
202014
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
F Ghasemi, M Black, F Vizeacoumar, N Pinto, KM Ruicci, CCSH Le, ...
Oncotarget 8 (42), 71512, 2017
182017
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition
KM Ruicci, N Pinto, MI Khan, J Yoo, K Fung, D MacNeil, JS Mymryk, ...
Oral oncology 84, 95-103, 2018
172018
A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
KM Ruicci, J Meens, RX Sun, G Rizzo, N Pinto, J Yoo, K Fung, D MacNeil, ...
International journal of cancer 145 (8), 2100-2106, 2019
162019
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
F Ghasemi, SD Prokopec, D MacNeil, N Mundi, SF Gameiro, C Howlett, ...
JCI insight 4 (1), 2019
152019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ...
Molecular oncology 13 (10), 2160-2177, 2019
122019
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
F Ghasemi, M Black, RX Sun, F Vizeacoumar, N Pinto, KM Ruicci, J Yoo, ...
Oncotarget 9 (40), 26064, 2018
92018
The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses
N Mundi, S Um, J Yoo, G Rizzo, M Black, N Pinto, DA Palma, K Fung, ...
Virus research 190, 53-59, 2014
82014
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
N Mundi, SD Prokopec, F Ghasemi, A Warner, K Patel, D MacNeil, ...
Cancers of the head & neck 4 (1), 1-8, 2019
62019
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
N Pinto, SD Prokopec, F Vizeacoumar, K Searle, M Lowerison, KM Ruicci, ...
PloS one 13 (11), e0207152, 2018
62018
Feasibility of targeting PIK3CA mutations in head and neck squamous cell carcinoma
JA Theurer, W Stecho, J Yoo, K Kwan, B Wehrli, V Harry, M Black, N Pinto, ...
Pathology & Oncology Research 22 (1), 35-40, 2016
62016
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer
M Black, F Ghasemi, RX Sun, W Stecho, A Datti, J Meens, N Pinto, ...
Oral oncology 101, 104529, 2020
32020
Feasibility and Acceptability of an Asthma App to Monitor Medication Adherence: Mixed Methods Study
C Jácome, R Almeida, AM Pereira, R Amaral, S Mendes, M Alves-Correia, ...
JMIR mHealth and uHealth 9 (5), e26442, 2021
22021
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
KM Ruicci, J Meens, P Plantinga, W Stecho, N Pinto, J Yoo, K Fung, ...
Journal of Experimental & Clinical Cancer Research 39 (1), 1-18, 2020
22020
Determinants of Implementation of a Clinical Practice Guideline for Homeless Health
O Magwood, A Hanemaayer, A Saad, G Salvalaggio, G Bloch, A Moledina, ...
International journal of environmental research and public health 17 (21), 7938, 2020
22020
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ...
Molecular oncology 14 (1), 230, 2020
22020
GRADE Concept Paper 1: Validating the “FACE” instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implement
K Pottie, O Magwood, P Rahman, T Concannon, P Alonso-Coello, ...
Journal of Clinical Epidemiology 131, 133-140, 2021
12021
Cross-cultural validation of the Portuguese from Portugal version of the test for respiratory and asthma control in kids questionnaire.
P Leiria-Pinto, J Marques, E Finelli, C Alves, M Alves, D Trincão, N Pinto, ...
European Annals of Allergy and Clinical Immunology, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20